New Stock News | Boji Pharmaceutical-B (02659.HK) IPO is highly sought after: International placement is oversubscribed by 6.59 times, long-term capital firmly entering.

According to the financial app of Wisdom Finance, on December 9, Baoji Pharmaceutical-B (02659.HK) successfully completed a new stock issuance of approximately 1 billion Hong Kong dollars. This issuance has attracted wide attention in the capital market, with particularly enthusiastic market response. Looking at the specific subscription data, the international allocation of the IPO received 6.59 times subscription, while the public offering in Hong Kong received 3526.34 times subscription, showing a high level of market participation. Baoji Pharmaceutical Co., Ltd. is expected to start trading on the Hong Kong Stock Exchange on December 10, 2025. In addition, the grey market trading of Baoji Pharmaceutical Co., Ltd. has been rising sharply, with Futu Securities showing a price of 56 Hong Kong dollars at the close of the market, an increase of 112.28% from the offering price of 26.38 Hong Kong dollars.